Gavric Gavric AU AU Ocvirk Ocvirk J J Mekjavic Mekjavic PJ PJ Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib Radiol Oncol Radiol Oncol 2018 2018 52 52 213 213 219 219 10.2478/raon-2018-0002 10.2478/raon-2018-0002 30018526 30018526. This evidence concerns the gene MAP2K7 and metastatic melanoma.